InvestorsHub Logo
Followers 44
Posts 15220
Boards Moderated 0
Alias Born 09/16/2012

Re: Chiugray post# 690332

Friday, 05/10/2024 12:42:13 PM

Friday, May 10, 2024 12:42:13 PM

Post# of 694146
Why would NICE pay hundreds of thousands for a possible 5% advancement in five year survival while still needing SOC and with 87/100 patients having no ‘meaningful’ benefit from its use, and with no pediatric data or stunning animal data?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News